News

April 4, 2012 — Medtronic Inc. announced that the Symplicity renal denervation system provides safe, significant and sustained blood pressure reduction up to three years in patients with treatment...

April 4, 2012 — Edwards Lifesciences Corp. reported that longer-term results (≥ 2 years) from the high-risk Cohort A of the PARTNER Trial – a randomized comparison of patients treated with either...

April 4, 2012 — Medrad (Bayer) recently introduced the Mark 7 Arterion angiographic contrast injection system. The system is much smaller, lighter-weight, more ergonomic and easier to maneuver...

Incidences of renal complications, specifically acute renal failure (ARF) and new hemodialysis (HD), continue to increase significantly among Medicare beneficiaries (MB) admitted for percutaneous...

A new comparative effectiveness study found older adults with stable coronary disease who underwent coronary artery bypass graft had better long-term survival than those who underwent percutaneous...

Interventional radiology treatments re-establish blood flow in people with chronic deep vein thrombosis (DVT), reducing disabling symptoms and improving the quality of life for those afflicted...

Patients who underwent transcatheter aortic valve implantation (TAVI) at experienced medical centers had significant improvement in valve function as well as low mortality and stroke rates at 30...

March 29, 2012 — Non-cardiac co-morbidities such as chronic obstructive pulmonary disease, chronic kidney disease and frailty are the main predictors of late mortality after transcatheter aortic...

Two-year follow-up data from the pivotal PLATINUM Workhorse trial comparing the safety and effectiveness of the Promus Element and Xience V everolimus-eluting coronary stents demonstrated superior...

March 29, 2012 — In the second year of an ongoing trial, the Resolute zotarolimus-eluting stent (Medtronic) achieved a low rate of stent thrombosis, cardiac death, target vessel heart attack and...

March 29, 2012 — Adding vorapaxar, an investigational platelet blocker, to standard antiplatelet therapy significantly reduces the risk of recurrent cardiovascular events in a specific group of...

The American College of Cardiology (ACC) 2012 Scientific Session, held March 24-27 in Chicago, was the first major cardiology show this year for vendors to display their latest innovations. A...

March 29, 2012 — St. Jude Medical Inc. announced it has received U.S. Food and Drug Administration (FDA) clearance for multiple enhancements to its PressureWire Fractional Flow Reserve (FFR)...

March 29, 2012 — Siemens Healthcare recently expanded its solutions portfolio by offering the RaySafe i2 personal dosimetry system as an accessory for all Siemens Artis zee angiography systems. By...

GE Healthcare unveiled two recently U.S. Food and Drug Administration (FDA)-cleared angiography systems offering mobility and advanced imaging for interventional cardiology at the American College...

New evidence shows that with appropriate preparation, angioplasty can be safely and effectively performed at community hospitals without on-site cardiac surgery units. This was according to data...

Coronary angiography is unable to accurately predict the severity of vessel narrowing, suggesting fractional flow reserve (FFR) functional tests should be added to help determine if a patient...

March 27, 2012 – Researchers found the antiplatelet drug abciximab significantly decreased damage to the heart muscle in patients with ST-segment-elevation myocardial infarction (STEMI), the most...

Biodegradable polymer drug-eluting stents (DES) provide better long-term safety and efficacy than durable polymer DES, according to findings from an analysis of three major clinical trials — ISAR-...

March 26, 2012 — Maquet announced positive long-term mortality results from the Balloon Pump-Assisted Coronary Intervention Study (BCIS-1), which evaluated the effect on major complications and...

March 23, 2012 — Improving the ability to diagnose cardiac disease with advanced ultrasound imaging, Toshiba America Medical Systems Inc. will showcase the newest additions to its ultrasound...

March 22, 2012 — Infraredx Inc. announced that its TVC Imaging System for the true vessel characterization of coronary artery disease will be featured in 11 oral and poster presentations,...

Addressing concerns over radiation from cardiac imaging and procedures, the American College of Cardiology Foundation (ACCF), Duke University Clinical Research Institute (DCRI) and American Heart...

March 20, 2012 – The Society for Cardiovascular Angiography and Interventions (SCAI) published a first-of-its-kind paper defining best practices in the cardiac catheterization laboratory, commonly...

March 20, 2012 - MarBlue Medical announced the global product launch of its CE-marked drug-eluting balloon (DEB) Protege as well as its CoCr stent on DEB Pioneer. The full market launch of the new...

Jack Miller, 62, is probably the only politician in America who smiles when people call him “heartless.” Four months ago, doctors at Virginia Commonwealth University (VCU) Medical Center in...

March 16, 2012 -- Kensey Nash Corp. today announced that the company has entered into a $39 million settlement agreement with St. Jude Medical, which resolves all disputes between the two...

March 16, 2012 — The U.S. Food and Drug Administration (FDA) approved the premarket approval (PMA) application for the Covidien EverFlex self-expanding peripheral stent system.

March 16, 2012 — Epocrates is releasing two new, free mobile device applications for cardiologists during the American College of Cardiology 2012 meeting.

March 16, 2012 - Stroke survivors who like art have a significantly higher quality of life than those who do not, according to new research. Patients who appreciated music, painting and...

March 16, 2012 – Medistim’s VeriQ system, which uses ultrasound to assess graft blood flow during coronary artery bypass graft (CABG) surgery, recently withstood the clinical scrutiny of the...

March 16, 2012 - Depression increases the risk of death in patients who have a coronary stent implanted. After seven years of follow up, depressed patients were 1.5 times more likely to have died...

March 15, 2012 — According to Millennium Research Group (MRG) the interventional cardiology (IC) market in Pakistan, Saudi Arabia, South Africa and Turkey will reach a value of more than $460...

March 13, 2012 — Asahi Kasei Corp.  and Zoll Medical Corp. jointly announced that Asahi Kasei will acquire Zoll for approximately $2.21 billion.

March 12, 2012 — Siemens Healthcare announced shipment of the Acuson S1000 ultrasound system, a premium ultrasound platform. The Acuson S1000 system expands access to imaging performance at a very...

March 9, 2012 - Researchers say venom from the green mamba snake may aid in the preservation of cardiac and renal function following serious cardiovascular events, such as heart attack and acute...

March 9, 2012 — Avinger Inc. announced the enrollment of the first U.S. patient in the CONNECT II global clinical trial evaluating the safety and efficacy of Ocelot. The device is the first...

March 8, 2012 — Edwards Lifesciences Corp. reported March 3 it filed its official response to the Centers for Medicare and Medicaid Services (CMS) on its proposed national coverage determination (...

March 7, 2012 — Four leading heart organizations representing cardiologists and cardiothoracic surgeons released initial recommendations for creating and maintaining transcatheter aortic valve...

March 6, 2012 — In a development that brings advanced combination therapy treatment of peripheral artery disease (PAD) to Japanese patients for the first time, Cook Medical has received PMDA...

March 6, 2012 — Vascular Magnetics announced it has raised $7 million to advance development of a drug delivery system using magnetically targeted nanoparticles to treat peripheral artery disease...

March 5, 2012 — SynCardia Systems Inc., manufacturer of the world’s first and only U.S. Food and Drug Administration (FDA), Health Canada and Conformité Européenne (CE) approved Total Artificial...

March 1, 2012 – Steris Corp. announced they will collaborate with device manufacturer St. Jude Medical Inc. on the planning and implementation of advanced cardiac laboratories for healthcare...

February 29, 2012 — Vessix Vascular Inc. announced initial patient treatments in the international multi-center Reduce-HTN renal denervation clinical study for uncontrolled hypertension.

February 29, 2012 — Lantheus Medical Imaging Inc. announced a strategic distribution arrangement for its Definity cardiac ultrasound contrast agent in the People’s Republic of China, including...

February 28, 2012 — Janssen Research and Development LLC announced that the U.S. Food and Drug Administration (FDA) has assigned a priority review designation to the supplemental new drug...

February 28, 2012 — AccessClosure Inc. announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of the MynxGrip Vascular Closure Device (VCD). Built on the Mynx platform, the...

Jarvik Heart Inc. announced conditional U.S. Food and Drug Administration (FDA) approval of its pivotal trial for evaluation of the Jarvik 2000 heart for destination therapy (DT). Use of the...

Avinger Inc. announced the enrollment of the first European patient in the CONNECT II global clinical trial. The first patient was enrolled by Dr. Bernhard Reimers at Ospedale di Mirano in Mirano...

February 24, 2012 — 3-D Surgical Solutions LLC and Wheaton Franciscan-The Wisconsin Heart Hospital Campus announced that the first case ever using the Leonardo 3-D vision system was successfully...

February 24, 2012 — A new report released today by HealthGrades found that from 2008 to 2010, emergency admissions for heart attack decreased slightly (1.7 percent) for Medicare patients, but...

February 24, 2012 — Simbionix USA Corp. announced that it received U.S. Food and Drug Administration (FDA) clearance for the endovascular aneurysm repair (EVAR) application for the PROcedure...

The U.S. Food and Drug Administration (FDA) granted the first coronary stent indication for use in patients experiencing an acute myocardial infarction (AMI), or heart attack. The Boston...

Teleflex Inc. announced a new agreement with HealthTrust Purchasing Group L.P. (HealthTrust), for its Arrow Intra-Aortic Balloon Pump and Catheter products. The new agreement begins March 1, 2012...

February 22, 2012 — HeartWare International Inc. announced that a U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel will review the premarket approval (PMA) application for...

PARADISE

February 20, 2012 — ReCor Medical announced that its Paradise percutaneous ultrasound renal denervation system for achieving rhas received the CE mark. Paradise is designed to treat patients with...

February 20, 2012 —Medtronic announced U.S. Food and Drug Administration (FDA) approval of the Resolute Integrity drug-eluting stent (DES)...

February 20, 2012 — Edwards Lifesciences Corp. announced that it received CE mark in Europe for its Edwards Intuity valve system for use in patients undergoing surgical aortic valve replacement (...

As catheter-based, minimally invasive procedures expand rapidly beyond treatment of the coronary arteries into all areas of the human anatomy, angiography X-ray imaging systems have moved beyond...

February 16, 2012 — A partnership between the American Society of Echocardiography (ASE) and GE Healthcare used technological innovations in the field to bring cardiovascular ultrasound to an...

February 16, 2012 — Few hospitals have as much experience with the Berlin Heart pediatric ventricular assist device (VAD) as DMC Children's Hospital of Michigan. This is why the U.S. Food and Drug...

February 16, 2012 — Siemens Healthcare received clearance from the U.S. Food and Drug Administration (FDA) for syngo Aortic ValveGuide, an integrated image processing software that helps...

February 16, 2012 — Velomedix Inc., a clinical stage medical device company, announced it has received investigational device exemption (IDE) approval from the U.S. Food and Drug Administration (...

February 16, 2012 — Aptus Endosystems, a company developing advanced technology for endovascular aneurysm repair (EVAR), announced the start of ANCHOR; a global, multicenter, prospective post-...

February 15, 2012 — Vessix Vascular Inc., developer of a novel percutaneous radiofrequency (RF) balloon catheter technology, announced that it will make its first detailed public presentation of...

February 15, 2012 — Medtronic Inc. announced the start of two clinical initiatives evaluating the broader, real-world clinical use of the company’s Symplicity renal denervation system across...

February 10, 2012—Merit Medical Systems recently announced it acquired the assets of Ostial Solutions LLC, maker of the Ostial Pro stent positioning system.

February 9, 2012 — The U.S. Food and Drug Administration (FDA) sent a warning letter to Merit Medical Systems Inc. regarding modifications to the hydrophilic coating process for the Merit Laureate...

February 9, 2012 — Stereotaxis Inc. said its Vdrive robotic navigation system, which provides physicians the ability to remotely manipulate traditionally non-robotic catheters, is growing in...

February 9, 2012 — Boston Scientific announced the United States launch of the TruePath CTO device, designed to facilitate the crossing of chronic total occlusions (CTOs, or complete blockages)...

February 9, 2012 — DSM announced a successful collaboration with medical manufacturer EPflex Feinwerktechnik GmbH to launch a new set of guidewires with ComfortCoat hydrophilic coating, a...

Provation MD

February 9, 2012 — Wolters Kluwer Health announced King’s Daughters Medical Center has selected its ProVation MD software for cardiology procedure documentation and coding in its cardiac...

February 6, 2012 — InspireMD Inc. announced positive clinical results for its MGuard stent from a controlled randomized trial conducted in Chile.

February 3, 2012 — Colibri Heart Valve received an notification it received patents for a new transcatheter heart valve from the United States Patent and Trademark Office.